Park Medi World Limited is an India-based company, which operates a private hospital chain in North India. It operates a network of over 13 National Accreditation Board for Hospitals & Healthcare Providers (NABH) accredited multi-super specialty hospitals under the Park brand, of which seven hospitals are also NABL accredited, with eight hospitals in Haryana, one hospital in New Delhi, two hospitals in Punjab and two hospitals in Rajasthan. It offers over 30 super specialty and specialty services, including internal medicine, neurology, urology, gastroenterology, cardiology, general surgery, orthopedics and oncology. Its specialties include cardiac sciences, neurosciences - brain & spine, plastic & cosmetic surgery, general and laparoscopic surgery, renal sciences & kidney transplant, and others. Its multi specialties include bariatric surgery, anesthesiology, critical care, chest & respiratory diseases, dermatology, endocrinology, internal medicine & geriatrics, and others.As of 25 May 2026, PARK MEDI WORLD LIMITED share price is ₹279.09. The stock opened at ₹264.50, compared to its previous close of ₹259.19. During today's trading session, PARK MEDI WORLD LIMITED share price moved in the range of ₹263.08 to ₹282.30, with an average price of ₹272.69 for the day. Looking at its last 52-week, the stock has touched a low of ₹263.08 and a high of ₹282.30. On the performance front, PARK MEDI WORLD LIMITED share price has increased by 75.19% over the last six months and is up 75.19% on a year-on-year basis.
The market capitalization of PARK MEDI WORLD LIMITED is ₹11,207 Crs, with a P/E ratio of 41.0 and a dividend yield of 0.00%.